Drug information for STELAZINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CONCENTRATE; ORAL EQ 10MG BASE/ML Discontinued   TRIFLUOPERAZINE HYDROCHLORIDE Trifluoperazine GLAXOSMITHKLINE 11552
2003-02-04 Review

2001-04-03 Letter
INJECTABLE; INJECTION EQ 2MG BASE/ML Discontinued   TRIFLUOPERAZINE HYDROCHLORIDE Trifluoperazine GLAXOSMITHKLINE   "
TABLET; ORAL EQ 10MG BASE Discontinued   TRIFLUOPERAZINE HYDROCHLORIDE Trifluoperazine GLAXOSMITHKLINE   "
TABLET; ORAL EQ 1MG BASE Discontinued   TRIFLUOPERAZINE HYDROCHLORIDE Trifluoperazine GLAXOSMITHKLINE   "
TABLET; ORAL EQ 2MG BASE Discontinued   TRIFLUOPERAZINE HYDROCHLORIDE Trifluoperazine GLAXOSMITHKLINE   "
TABLET; ORAL EQ 5MG BASE Discontinued   TRIFLUOPERAZINE HYDROCHLORIDE Trifluoperazine GLAXOSMITHKLINE   "

Drug Adverse Effects information for STELAZINE

Role code Indications Reaction # Reports
C ARTHRITIS CONSTIPATION 2
C ARTHRITIS GOUT 2
C ARTHRITIS URINARY INCONTINENCE 2
C ARTHROPATHY CONSTIPATION 2
C ARTHROPATHY GOUT 2
C ARTHROPATHY URINARY INCONTINENCE 2
C BIPOLAR DISORDER BLOOD CHOLESTEROL INCREASED 1
C BIPOLAR DISORDER BLOOD TRIGLYCERIDES INCREASED 1
C BIPOLAR DISORDER BLOOD URINE PRESENT 1
C BIPOLAR DISORDER BRONCHITIS 1
C BIPOLAR DISORDER CATARACT 1
C BIPOLAR DISORDER CHEST PAIN 1
C BIPOLAR DISORDER DIABETES MELLITUS 1
C BIPOLAR DISORDER HYPERTENSION 1
C BIPOLAR DISORDER RENAL FAILURE 1
C BIPOLAR DISORDER WEIGHT INCREASED 1
C BLADDER DISORDER CONSTIPATION 2
C BLADDER DISORDER GOUT 2
C BLADDER DISORDER URINARY INCONTINENCE 2
C CARDIAC DISORDER CONSTIPATION 2
C CARDIAC DISORDER GOUT 2
C CARDIAC DISORDER URINARY INCONTINENCE 2
C CARDIAC FAILURE CONSTIPATION 2
C CARDIAC FAILURE GOUT 2
C CARDIAC FAILURE URINARY INCONTINENCE 2
C DEPRESSION CONSTIPATION 2
C DEPRESSION FATIGUE 1
C DEPRESSION GOUT 2
C DEPRESSION INSOMNIA 1
C DEPRESSION MIGRAINE 1
C DEPRESSION URINARY INCONTINENCE 2
C HYPERTENSION CONSTIPATION 6
C HYPERTENSION GOUT 6
C HYPERTENSION URINARY INCONTINENCE 6
C MACULAR DEGENERATION CONSTIPATION 2
C MACULAR DEGENERATION GOUT 2
C MACULAR DEGENERATION URINARY INCONTINENCE 2
C MICTURITION DISORDER CONSTIPATION 2
C MICTURITION DISORDER GOUT 2
C MICTURITION DISORDER URINARY INCONTINENCE 2
C MIGRAINE FATIGUE 1
C MIGRAINE INSOMNIA 1
C MIGRAINE MIGRAINE 1
C PRODUCT USED FOR UNKNOWN INDICATION AGGRESSION 1
C PRODUCT USED FOR UNKNOWN INDICATION HEADACHE 1
C PRODUCT USED FOR UNKNOWN INDICATION PRURITUS 1
C PRODUCT USED FOR UNKNOWN INDICATION SWELLING 1
C SCHIZOPHRENIA ANAEMIA 2
C SCHIZOPHRENIA ARTERIAL OCCLUSIVE DISEASE 1
C SCHIZOPHRENIA ASTHMA 1
C SCHIZOPHRENIA BRONCHITIS 1
C SCHIZOPHRENIA CEREBROVASCULAR ACCIDENT 2
C SCHIZOPHRENIA CHEST DISCOMFORT 1
C SCHIZOPHRENIA DEATH 1
C SCHIZOPHRENIA DEPRESSION 2
C SCHIZOPHRENIA DIABETES MELLITUS 3
C SCHIZOPHRENIA DIABETIC KETOACIDOSIS 2
C SCHIZOPHRENIA FATIGUE 2
C SCHIZOPHRENIA HYPERSOMNIA 2
C SCHIZOPHRENIA MEMORY IMPAIRMENT 2
C SCHIZOPHRENIA MENTAL IMPAIRMENT 2
C SCHIZOPHRENIA NEOPLASM MALIGNANT 1
C SCHIZOPHRENIA NEUTROPHIL COUNT INCREASED 1
C SCHIZOPHRENIA OEDEMA PERIPHERAL 2
C SCHIZOPHRENIA OVERDOSE 2
C SCHIZOPHRENIA PANCREATITIS 2
C SCHIZOPHRENIA PYREXIA 2
C SCHIZOPHRENIA RENAL FAILURE 2
C SCHIZOPHRENIA THROMBOCYTOPENIA 2
C SCHIZOPHRENIA WHITE BLOOD CELL COUNT INCREASED 1
I PARKINSON'S DISEASE BLOOD CREATINE PHOSPHOKINASE INCREASED 1
I PARKINSON'S DISEASE DRUG INTERACTION 1
I PARKINSON'S DISEASE NEUROLEPTIC MALIGNANT SYNDROME 1
I PARKINSON'S DISEASE SCHIZOPHRENIA 1
I PARKINSON'S DISEASE SEDATION 1
I SCHIZOPHRENIA BLOOD CREATINE PHOSPHOKINASE INCREASED 1
I SCHIZOPHRENIA DRUG INTERACTION 1
I SCHIZOPHRENIA NEUROLEPTIC MALIGNANT SYNDROME 1
I SCHIZOPHRENIA SCHIZOPHRENIA 1
I SCHIZOPHRENIA SEDATION 1
Ads by Google